Covid-19 Drug interactions
The Liverpool Drug Interactions website team developed a freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and commonly prescribed co-medications.
Find out more here.
We’ve published a video explaining the work we have done in 2020 to bring you the COVID-19 Drug Interactions website.
— COVID-19 Drug Interactions (@covidDDIs) October 12, 2020
COVID-19: Dangerous drug combinations? https://t.co/yAvptS9952 via @YouTube
Other posts
GlaxoSmithKline and Vir Biotechnology have joined forces with researchers from the Universities of Liverpool and Southampton, who are leading an accelerated early phase trials platform…
An experimental drug that could prevent Covid-19 patients from becoming seriously ill is being trialled in England. The BBC’s Fergus Walsh spoke to two volunteers…
Take a look at this case study from @Medidata who are supporting @SouthamptonCTU with the AGILE clinical trial platform #COVID19 #clinicaltrials
The Liverpool Drug Interactions website team developed a freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents…
The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit announced this week that they have launched their innovative COVID-19 drug…